PRECISION ENGINEERED MOLECULAR ASSAYS

BioGene designs and validates high sensitivity & specificity molecular assays, specifically optimised for deployment using the CENOS™ platform.

Our advanced in-silico pipeline models primer and probe hybridisation, across genetically diverse pathogens, including highly heterogeneous viruses, enabling precise multiplex detection.

VALIDATED PERFORMANCE

• Sensitive: ≤5 copies per reaction sensitivity
• Performance Driven: detects <1,000 genomes per swab or ml of blood
• Xtraction Free: direct detection from crude samples — no extraction required
• High Specificity: tested against unrelated high-titre pathogens
• Multiplex Detection: supports differential testing for blood-borne and respiratory threats

We design, validate, and deploy new assays within 8 weeks of sequence release, under our ISO 13485 validated processes.

We can port and optimise existing assays onto the CENOS™ platform, aligning performance with our proprietary system architecture.

Deployed beyond the laboratory — into field and satellite environments at the Point-of-Decision.